Authors:
TROLLFORS B
TARANGER J
LAGERGARD T
SUNDH V
BRYLA DA
SCHNEERSON R
ROBBINS JB
Citation: B. Trollfors et al., IMMUNIZATION OF CHILDREN WITH PERTUSSIS TOXOID DECREASES SPREAD OF PERTUSSIS WITHIN THE FAMILY, The Pediatric infectious disease journal, 17(3), 1998, pp. 196-199
Authors:
VIDARSSON G
SIGURDARDOTTIR ST
GUDNASON T
KJARTANSSON S
KRISTINSSON KG
INGOLFSDOTTIR G
JONSSON S
VALDIMARSSON H
SCHIFFMAN G
SCHNEERSON R
JONSDOTTIR I
Citation: G. Vidarsson et al., ISOTYPES AND OPSONOPHAGOCYTOSIS OF PNEUMOCOCCUS TYPE 6B ANTIBODIES ELICITED IN INFANTS AND ADULTS BY AN EXPERIMENTAL PNEUMOCOCCUS TYPE 6B-TETANUS TOXOID VACCINE, Infection and immunity, 66(6), 1998, pp. 2866-2870
Authors:
SIGURDARDOTTIR ST
VIDARSSON G
GUDNASON T
KJARTANSSON S
KRISTINSSON KG
JONSSON S
VALDIMARSSON H
SCHIFFMAN G
SCHNEERSON R
JONSDOTTIR I
Citation: St. Sigurdardottir et al., IMMUNE-RESPONSES OF INFANTS VACCINATED WITH SEROTYPE 6B PNEUMOCOCCAL POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID, The Pediatric infectious disease journal, 16(7), 1997, pp. 667-674
Authors:
ROBBINS JB
TOWNE DW
GOTSCHLICH EC
SCHNEERSON R
Citation: Jb. Robbins et al., LOVES LABORS LOST - FAILURE TO IMPLEMENT MASS VACCINATION AGAINST GROUP-A MENINGOCOCCAL MENINGITIS IN SUB-SAHARAN AFRICA, Lancet, 350(9081), 1997, pp. 880-882
Authors:
COHEN D
ASHKENAZI S
GREEN MS
GDALEVICH M
ROBIN G
SLEPON R
YAVZORI M
ORR N
BLOCK C
ASHKENAZI I
SHEMER J
TAYLOR DN
HALE TL
SADOFF JC
PAVLIAKOVA D
SCHNEERSON R
ROBBINS JB
Citation: D. Cohen et al., DOUBLE-BLIND VACCINE-CONTROLLED RANDOMIZED EFFICACY TRIAL OF AN INVESTIGATIONAL SHIGELLA-SONNEI CONJUGATE VACCINE IN YOUNG-ADULTS, Lancet, 349(9046), 1997, pp. 155-159
Citation: G. Batta et al., CONFORMATIONAL STABILIZATION OF THE ALTRURONIC ACID RESIDUE IN THE O-SPECIFIC POLYSACCHARIDE OF SHIGELLA-SONNEI PLESIOMONAS-SHIGELLOIDES, Carbohydrate research, 305(1), 1997, pp. 93-99
Authors:
MADORE DV
ANDERSON P
BAXTER BD
CARLONE GM
EDWARDS KM
HAMILTON RG
HOLDER P
KAYHTY H
PHIPPS DC
PEETERS CCA
SCHNEERSON R
SIBER GR
WARD JI
FRASCH CE
Citation: Dv. Madore et al., INTERLABORATORY STUDY EVALUATING QUANTITATION OF ANTIBODIES TO HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY, Clinical and diagnostic laboratory immunology, 3(1), 1996, pp. 84-88
Authors:
WELCH PG
FATTOM A
MOORE J
SCHNEERSON R
SHILOACH J
BRYLA DA
LI XR
ROBBINS JB
Citation: Pg. Welch et al., SAFETY AND IMMUNOGENICITY OF STAPHYLOCOCCUS-AUREUS TYPE 5 CAPSULAR POLYSACCHARIDE-PSEUDOMONAS-AERUGINOSA RECOMBINANT EXOPROTEIN-A CONJUGATEVACCINE IN PATIENTS ON HEMODIALYSIS, Journal of the American Society of Nephrology, 7(2), 1996, pp. 247-253
Authors:
CLAESSON BA
TROLLFORS B
ANDERSON PW
JOHANSSON J
TARANGER J
SCHNEERSON R
ROBBINS JB
Citation: Ba. Claesson et al., SERUM ANTIBODIES IN 6-YEAR-OLD CHILDREN VACCINATED IN INFANCY WITH A HAEMOPHILUS-INFLUENZAE TYPE-B-TETANUS TOXOID CONJUGATE VACCINE, The Pediatric infectious disease journal, 15(2), 1996, pp. 170-172
Authors:
MILLER CE
KARPAS A
SCHNEERSON R
HUPPI K
KOVAC P
POZSGAY V
GLAUDEMANS CPJ
Citation: Ce. Miller et al., OF 4 MURINE, ANTI-SHIGELLA DYSENTERIAE TYPE-1 O-POLYSACCHARIDE ANTIBODIES, 3 EMPLOY V-GENES THAT DIFFER EXTENSIVELY FROM THOSE OF THE 4TH, Molecular immunology, 33(16), 1996, pp. 1217-1222
Authors:
ROBBINS JB
SCHNEERSON R
ANDERSON P
SMITH DH
Citation: Jb. Robbins et al., PREVENTION OF SYSTEMIC INFECTIONS, ESPECIALLY MENINGITIS, CAUSED BY HAEMOPHILUS-INFLUENZAE TYPE-B - IMPACT ON PUBLIC-HEALTH AND IMPLICATIONS FOR OTHER POLYSACCHARIDE-BASED VACCINES, JAMA, the journal of the American Medical Association, 276(14), 1996, pp. 1181-1185
Authors:
COHEN D
ASHKENAZI S
GREEN M
LERMAN Y
SLEPON R
ROBIN G
ORR N
TAYLOR DN
SADOFF JC
CHU CY
SHILOACH J
SCHNEERSON R
ROBBINS JB
Citation: D. Cohen et al., SAFETY AND IMMUNOGENICITY OF INVESTIGATIONAL SHIGELLA CONJUGATE VACCINES IN ISRAELI VOLUNTEERS, Infection and immunity, 64(10), 1996, pp. 4074-4077
Authors:
SARNAIK SA
SIMPSON P
KAPLAN J
SCHIFFMAN G
SCHNEERSON R
Citation: Sa. Sarnaik et al., RESPONSE TO CONJUGATE PNEUMOCOCCAL VACCINE TYPE 6B-TT IN INFANTS WITHSICKLE-CELL DISEASES, Pediatric research, 37(4), 1995, pp. 187-187
Citation: Jb. Robbins et al., PERSPECTIVE - HYPOTHESIS - SERUM IGG ANTIBODY IS SUFFICIENT TO CONFERPROTECTION AGAINST INFECTIOUS-DISEASES BY INACTIVATING THE INOCULUM, The Journal of infectious diseases, 171(6), 1995, pp. 1387-1398
Authors:
LIAO J
NICKERSON KG
BYSTRICKY S
ROBBINS JB
SCHNEERSON R
SZU SC
KABAT EA
Citation: J. Liao et al., CHARACTERIZATION OF A HUMAN MONOCLONAL IMMUNOGLOBULIN-M (IGM) ANTIBODY (IGM(BEN)) SPECIFIC FOR VI CAPSULAR POLYSACCHARIDE OF SALMONELLA-TYPHI, Infection and immunity, 63(11), 1995, pp. 4429-4432
Authors:
POLOTSKY VY
ROBBINS JB
BRYLA D
SCHNEERSON R
Citation: Vy. Polotsky et al., COMPARISON OF CONJUGATES COMPOSED OF LIPOPOLYSACCHARIDE FROM SHIGELLA-FLEXNERI TYPE-2A DETOXIFIED BY 2 METHODS AND BOUND TO TETANUS TOXOID, Infection and immunity, 62(1), 1994, pp. 210-214
Authors:
AVANZINI MA
BJORKANDER J
SODERSTROM R
SODERSTROM T
SCHNEERSON R
ROBBINS JB
HANSON LA
Citation: Ma. Avanzini et al., QUALITATIVE AND QUANTITATIVE-ANALYSES OF THE ANTIBODY-RESPONSE ELICITED BY HAEMOPHILUS-INFLUENZAE TYPE-B CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATES IN ADULTS WITH IGG SUBCLASS DEFICIENCIES AND FREQUENT INFECTIONS, Clinical and experimental immunology, 96(1), 1994, pp. 54-58
Authors:
ROBBINS JB
PITTMAN M
TROLLFORS B
LAGERGARD TA
TARANGER J
SCHNEERSON R
Citation: Jb. Robbins et al., PRIMUM-NON-NOCERE - A PHARMACOLOGICALLY INERT PERTUSSIS TOXOID ALONE SHOULD BE THE NEXT PERTUSSIS-VACCINE, The Pediatric infectious disease journal, 12(10), 1993, pp. 795-807
Authors:
PAVLIAK V
NASHED EM
POZSGAY V
KOVAC P
KARPAS A
CHU CY
SCHNEERSON R
ROBBINS JB
GLAUDEMANS CPJ
Citation: V. Pavliak et al., BINDING OF THE O-ANTIGEN OF SHIGELLA-DYSENTERIAE TYPE-1 AND TYPE-26 RELATED SYNTHETIC FRAGMENTS TO A MONOCLONAL IGM ANTIBODY, The Journal of biological chemistry, 268(34), 1993, pp. 25797-25802